EUVIMEDEUVIMED entdecken
Crossref

Betanin-encapsulated nanoparticles mitigate neurotoxicity against AlCl3-induced Alzheimer's disease via modulation of AChE/TNF-α/IL-1β expression

Rabbiya Razzaq, Touqeer Ahmed, Azeem Mehmood Butt, Zahra Jabeen, Aaima Khalid, Imran Shahid, Abdullah R Alzahrani, Sidra Rehman

Biochemical and Biophysical Research Communications · 2026

DOI: 10.1016/j.bbrc.2026.153293 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2026. Verfasst von Rabbiya Razzaq und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biosciences, COMSATS University Islamabad (CUI), Park Road, Islamabad, 45550, Pakistan. Hauptthemen laut MEDLINE: Alzheimer Disease, Betacyanins, Nanoparticles, Neuroprotective Agents. Die Arbeit nennt 44 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD), the most common health problem, is significantly characterized by oxidative stress, neuroinflammation, and cholinergic dysfunction, provoking growing interest in natural antioxidants with improved bioavailability. This study is intended to evaluate the neuroprotective impact and the probable mechanism of betanin and formulated betanin-encapsulated nanoparticles (ChBetNPs) in an AlCl3 and D-galactose-induced rat model Alzheimer's-like neurotoxicity. The rats were treated daily with AlCl3 and D-galactose for 21 days to induce neurotoxicity, followed by two weeks of treatment with low and high doses of betanin and ChBetNPs. After treatment, cognitive performance, oxidative stress markers, acetylcholinesterase (AChE) activity, and hippocampal inflammatory gene expression were assessed. Both low and high doses of ChBetNPs (40 mg/kg/day and 80 mg/kg/day respectively) significantly improved learning and memory performance in AlCl3 + D-galactose-treated rats. Treatment with ChBetNPs also markedly restored antioxidant defenses, as evidenced by increased activities of CAT (∗∗P < 0.01), elevated reduced GSH, and reduced levels of the lipid peroxidation marker MDA. The higher dose of ChBetNPs produced a pronounced protective effect on cholinergic function, reflected by a robust reduction in brain AChE activity (∗∗∗∗P < 0.0001). In addition, both free betanin and ChBetNPs at low and high doses significantly (∗∗P < 0.01) downregulated the hippocampal mRNA expression of AChE, α-synuclein, TNF-α, and IL-1β in hippocampal region of brain as compared with untreated group, indicating attenuation of neuroinflammatory and protein-aggregation-related pathways. In summary, our findings demonstrate that ChBetNPs enhanced learning, memory, and cholinergic neurotransmission, likely by mitigating oxidative stress and the associated NF-κB-mediated inflammatory responses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseBetacyaninsNanoparticlesNeuroprotective AgentsAnimalsAluminum ChlorideAcetylcholinesteraseTumor Necrosis Factor-alphaMaleRatsInterleukin-1betaOxidative StressHippocampusRats, WistarGalactose

Stichwörter der Autor:innen

Alzheimer's diseaseBetaninIn vivo screeningNanoparticlesNeuroinflammationOxidative stress

Substanzen

Aluminum ChloridebetaninBetacyaninsAcetylcholinesteraseTumor Necrosis Factor-alphaInterleukin-1betaNeuroprotective AgentsGalactose

Autor:innen und Institutionen

  • Department of Biosciences, COMSATS University Islamabad (CUI), Park Road, Islamabad, 45550, Pakistan.
  • Neurobiology Laboratory, Department of Healthcare Biotechnology, Atta-Ur-Rahman School of Applied Biosciences, National University of Sciences and Technology, Islamabad, 44000, Pakistan.
  • Department of Biosciences, COMSATS University Islamabad (CUI), Park Road, Islamabad, 45550, Pakistan; Comprehensive Cancer Centre, Guy's Hospital, King's College London, SE1 9RT, London, United Kingdom.
  • Azra Naheed Medical College, 17km Raiwind Rd, Kot Araian, Lahore, Pakistan.
  • Department of Pharmacology and Toxicology, Faculty of Medicine, Umm Al-Qura University, AlAbidiyah, P.O. Box 13578, Makkah, 21955, Saudi Arabia.
  • Department of Biosciences, COMSATS University Islamabad (CUI), Park Road, Islamabad, 45550, Pakistan. Electronic address: sidrarehman@comsats.edu.pk.

Zitieren

APA

Razzaq, R., Ahmed, T., Butt, A. M., Jabeen, Z., Khalid, A., Shahid, I., Alzahrani, A. R., & Rehman, S. (2026). Betanin-encapsulated nanoparticles mitigate neurotoxicity against AlCl3-induced Alzheimer's disease via modulation of AChE/TNF-α/IL-1β expression. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2026.153293

Vancouver

Razzaq R, Ahmed T, Butt AM, Jabeen Z, Khalid A, Shahid I, et al. Betanin-encapsulated nanoparticles mitigate neurotoxicity against AlCl3-induced Alzheimer's disease via modulation of AChE/TNF-α/IL-1β expression. Biochemical and Biophysical Research Communications. 2026. doi:10.1016/j.bbrc.2026.153293

BibTeX
@article{Razzaq2026,
  author = {Razzaq, Rabbiya and Ahmed, Touqeer and Butt, Azeem Mehmood and Jabeen, Zahra and Khalid, Aaima and Shahid, Imran and Alzahrani, Abdullah R and Rehman, Sidra},
  title = {Betanin-encapsulated nanoparticles mitigate neurotoxicity against AlCl3-induced Alzheimer's disease via modulation of AChE/TNF-α/IL-1β expression},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2026},
  doi = {10.1016/j.bbrc.2026.153293}
}
Kostenlos starten →